Outcomes of patients with initially unresectable pancreatic cancer who underwent conversion surgery after FOLFIRINOX or gemcitabine plus nab-paclitaxel chemotherapy: A multicenter retrospective cohort study (PC-CURE-1).
Okano N, Kawai M, Ueno M, Yu X, Inoue Y, Takahashi S, Wang W, Takahashi H, Okamura Y, Morinaga S, Matsumoto I, Shimizu Y, Yoshida K, Yamamoto T, Ohtsuka M, Inokawa Y, Nara S, Tamura J, Shinoda S, Yamamoto K, Yamaue H, Furuse J; PC‐CURE‐1 study group.
Okano N, et al. Among authors: yu x.
J Hepatobiliary Pancreat Sci. 2024 Nov;31(11):816-829. doi: 10.1002/jhbp.12066. Epub 2024 Aug 16.
J Hepatobiliary Pancreat Sci. 2024.
PMID: 39150050
Free PMC article.